136 related articles for article (PubMed ID: 38928061)
1. Monocytic Differentiation in Acute Myeloid Leukemia Cells: Diagnostic Criteria, Biological Heterogeneity, Mitochondrial Metabolism, Resistance to and Induction by Targeted Therapies.
Bruserud Ø; Selheim F; Hernandez-Valladares M; Reikvam H
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928061
[TBL] [Abstract][Full Text] [Related]
2. Monocytic Differentiation of Human Acute Myeloid Leukemia Cells: A Proteomic and Phosphoproteomic Comparison of FAB-M4/M5 Patients with and without Nucleophosmin 1 Mutations.
Selheim F; Aasebø E; Reikvam H; Bruserud Ø; Hernandez-Valladares M
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791118
[TBL] [Abstract][Full Text] [Related]
3. XIAP expression correlates with monocytic differentiation in adult de novo AML: impact on prognosis.
Tamm I; Richter S; Scholz F; Schmelz K; Oltersdorf D; Karawajew L; Schoch C; Haferlach T; Ludwig WD; Wuchter C
Hematol J; 2004; 5(6):489-95. PubMed ID: 15570290
[TBL] [Abstract][Full Text] [Related]
4. Monocytic AML cells inactivate antileukemic lymphocytes: role of NADPH oxidase/gp91(phox) expression and the PARP-1/PAR pathway of apoptosis.
Aurelius J; Thorén FB; Akhiani AA; Brune M; Palmqvist L; Hansson M; Hellstrand K; Martner A
Blood; 2012 Jun; 119(24):5832-7. PubMed ID: 22550344
[TBL] [Abstract][Full Text] [Related]
5. Expression of immune inhibitory receptor ILT3 in acute myeloid leukemia with monocytic differentiation.
Dobrowolska H; Gill KZ; Serban G; Ivan E; Li Q; Qiao P; Suciu-Foca N; Savage D; Alobeid B; Bhagat G; Colovai AI
Cytometry B Clin Cytom; 2013; 84(1):21-9. PubMed ID: 23027709
[TBL] [Abstract][Full Text] [Related]
6. Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemia.
Del Poeta G; Bruno A; Del Principe MI; Venditti A; Maurillo L; Buccisano F; Stasi R; Neri B; Luciano F; Siniscalchi A; de Fabritiis P; Amadori S
Curr Cancer Drug Targets; 2008 May; 8(3):207-22. PubMed ID: 18473734
[TBL] [Abstract][Full Text] [Related]
7. Selective eradication of venetoclax-resistant monocytic acute myeloid leukemia with iron oxide nanozymes.
Zhang S; Lou S; Bian W; Liu J; Wang R; Wang Y; Zhao Y; Zou X; Jin D; Liang Y; Sun J; Liu L
Biochem Biophys Res Commun; 2024 Jul; 719():150117. PubMed ID: 38761635
[TBL] [Abstract][Full Text] [Related]
8. Engagement of SIRPα inhibits growth and induces programmed cell death in acute myeloid leukemia cells.
Irandoust M; Alvarez Zarate J; Hubeek I; van Beek EM; Schornagel K; Broekhuizen AJ; Akyuz M; van de Loosdrecht AA; Delwel R; Valk PJ; Sonneveld E; Kearns P; Creutzig U; Reinhardt D; de Bont ES; Coenen EA; van den Heuvel-Eibrink MM; Zwaan CM; Kaspers GJ; Cloos J; van den Berg TK
PLoS One; 2013; 8(1):e52143. PubMed ID: 23320069
[TBL] [Abstract][Full Text] [Related]
9. Expression of the c-fgr and hck protein-tyrosine kinases in acute myeloid leukemic blasts is associated with early commitment and differentiation events in the monocytic and granulocytic lineages.
Willman CL; Stewart CC; Longacre TL; Head DR; Habbersett R; Ziegler SF; Perlmutter RM
Blood; 1991 Feb; 77(4):726-34. PubMed ID: 1825181
[TBL] [Abstract][Full Text] [Related]
10. Myelomonocytic and monocytic acute myeloid leukemia demonstrate comparable poor outcomes with venetoclax-based treatment: a monocentric real-world study.
Zhao L; Yang J; Chen M; Xiang X; Ma H; Niu T; Gong Y; Chen X; Liu J; Wu Y
Ann Hematol; 2024 Apr; 103(4):1197-1209. PubMed ID: 38329487
[TBL] [Abstract][Full Text] [Related]
11. Assessment of monocytic component in acute myelomonocytic and monocytic/monoblastic leukemias by a chemiluminescent assay.
da Fonseca LM; Brunetti IL; Campa A; Catalani LH; Calado RT; Falcão RP
Hematol J; 2003; 4(1):26-30. PubMed ID: 12692517
[TBL] [Abstract][Full Text] [Related]
12. De Novo Acute Myeloid Leukemia in Adults: Suppression of MicroRNA-223 is Independent of LMO2 Protein Expression BUT Associate With Adverse Cytogenetic Profile and Undifferentiated Blast Morphology.
Akhter A; Patel JL; Farooq F; Qureshi A; Taher-Rad MS; Elyamany G; Al-Zahrani AM; Rashid-Kolvear F; Mansoor A
Appl Immunohistochem Mol Morphol; 2015; 23(10):733-9. PubMed ID: 25710580
[TBL] [Abstract][Full Text] [Related]
13. Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia.
Kuusanmäki H; Dufva O; Vähä-Koskela M; Leppä AM; Huuhtanen J; Vänttinen I; Nygren P; Klievink J; Bouhlal J; Pölönen P; Zhang Q; Adnan-Awad S; Mancebo-Pérez C; Saad J; Miettinen J; Javarappa KK; Aakko S; Ruokoranta T; Eldfors S; Heinäniemi M; Theilgaard-Mönch K; Wartiovaara-Kautto U; Keränen M; Porkka K; Konopleva M; Wennerberg K; Kontro M; Heckman CA; Mustjoki S
Blood; 2023 Mar; 141(13):1610-1625. PubMed ID: 36508699
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial metabolism: powering new directions in acute myeloid leukemia.
Stubbins RJ; Maksakova IA; Sanford DS; Rouhi A; Kuchenbauer F
Leuk Lymphoma; 2021 Oct; 62(10):2331-2341. PubMed ID: 34060970
[TBL] [Abstract][Full Text] [Related]
15. The thymidine dideoxynucleoside analog, alovudine, inhibits the mitochondrial DNA polymerase γ, impairs oxidative phosphorylation and promotes monocytic differentiation in acute myeloid leukemia.
Yehudai D; Liyanage SU; Hurren R; Rizoska B; Albertella M; Gronda M; Jeyaraju DV; Wang X; Barghout SH; MacLean N; Siriwardena TP; Jitkova Y; Targett-Adams P; Schimmer AD
Haematologica; 2019 May; 104(5):963-972. PubMed ID: 30573504
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis targeted therapies in acute myeloid leukemia: an update.
Ball S; Borthakur G
Expert Rev Hematol; 2020 Dec; 13(12):1373-1386. PubMed ID: 33205684
[No Abstract] [Full Text] [Related]
17. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Schmetzer H
Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776
[TBL] [Abstract][Full Text] [Related]
18. The usefulness of CD64, other monocyte-associated antigens, and CD45 gating in the subclassification of acute myeloid leukemias with monocytic differentiation.
Krasinskas AM; Wasik MA; Kamoun M; Schretzenmair R; Moore J; Salhany KE
Am J Clin Pathol; 1998 Dec; 110(6):797-805. PubMed ID: 9844593
[TBL] [Abstract][Full Text] [Related]
19. The value of CD64 expression in distinguishing acute myeloid leukemia with monocytic differentiation from other subtypes of acute myeloid leukemia: a flow cytometric analysis of 64 cases.
Dunphy CH; Tang W
Arch Pathol Lab Med; 2007 May; 131(5):748-54. PubMed ID: 17488160
[TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of two novel cytokine-responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3.
Hu ZB; Ma W; Zaborski M; MacLeod R; Quentmeier H; Drexler HG
Leukemia; 1996 Jun; 10(6):1025-40. PubMed ID: 8667638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]